Aimed Alliance Submits Public Comment on ICER’s Flawed Drug Pricing Assessment 0 By Aimed Alliance on February 13, 2019 Aimed Activity, Comments & Sign-on Letters, Drug Pricing, Drug Pricing: Policy Activity, Resources, Value, Value: Policy Activity Last Updated on October 24, 2019 by Advocacy Value Share. Twitter Facebook Pinterest LinkedIn Tumblr Email
October 1, 2025 Aimed Alliance Shares Concerns Regarding Affordability Review Process with Oregon PDAB